Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, indicating a new release version without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-22T15:57:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a new PubMed publication entry for Shitara et al. on first-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma. The citation shows Nat Med 2026 Jun;32(6):2182-2190 with an Epub date of 2026 Mar 16, replacing the earlier Online ahead of print note.
    Difference
    0.0%
    Check dated 2026-07-15T13:23:06.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3, replacing the previous v3.6.0 on the page. This indicates a new site revision without altering study details.
    Difference
    0.0%
    Check dated 2026-07-01T10:17:53.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The study milestone dates were updated to Primary Completion: 2026-12-31 and Study Completion: 2027-11-30, with the last update posted on 2026-06-18, reflecting a refreshed timeline.
    Difference
    0.2%
    Check dated 2026-06-24T05:34:48.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Recruitment messaging now shows 'No longer looking for participants', the treatment label is standardized to 'Intervention/Treatment' (replacing 'Intervention / Treatment'), several help/navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision badge updates from v3.5.4 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-09T20:12:59.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and the previous revision v3.5.3 was removed, indicating a small metadata update to the page.
    Difference
    0.0%
    Check dated 2026-05-19T09:56:59.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.